Price Alert

Elanco Animal Health Inc (ELAT)

NYSE: ELAT · Real-Time Price · USD

21.32

0.22 (1.04%)

At close: Jan 31, 2023, 10:00 PM

Elanco Animal Health Inc Statistics

Share Statistics

Elanco Animal Health Inc has n/a shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	24,333
FTD / Avg. Volume	52.33%

Short Selling Information

The latest short interest is 53.01K, so 0% of the outstanding shares have been sold short.

Short Interest	53.01K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is 31.16 and the forward PE ratio is null. Elanco Animal Health Inc's PEG ratio is -0.24.

PE Ratio	31.16
Forward PE	n/a
PS Ratio	2.37
Forward PS	n/a
PB Ratio	1.73
P/FCF Ratio	26.73
PEG Ratio	-0.24

Financial Ratio History

Enterprise Valuation

Elanco Animal Health Inc has an Enterprise Value (EV) of 14.39B.

EV / Sales	3.24
EV / EBITDA	57.31
EV / EBIT	26.59
EV / FCF	36.51

Financial Position

The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.71.

Current Ratio	2.44
Quick Ratio	1.25
Debt / Equity	0.71
Debt / EBITDA	17.22
Debt / FCF	10.97
Interest Coverage	1.07

Financial Efficiency

Return on Equity is 5.54% and Return on Invested Capital is 1.53%.

Return on Equity	5.54%
Return on Assets	2.68%
Return on Invested Capital	1.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	undefined
Asset Turnover	0.35
Inventory Turnover	1.61

Taxes

Income Tax	150M
Effective Tax Rate	30.74%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0, so Elanco Animal Health Inc's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	19.81
200-Day Moving Average	26.93
Relative Strength Index (RSI)	9.27
Average Volume (20 Days)	46,495

Income Statement

In the last 12 months, Elanco Animal Health Inc had revenue of 4.44B and earned 338M in profits. Earnings per share was 0.68.

Revenue	4.44B
Gross Profit	1.91B
Operating Income	251M
Net Income	338M
EBITDA	251M
EBIT	n/a
Earnings Per Share (EPS)	0.68

Full Income Statement

Balance Sheet

The company has 468M in cash and 4.32B in debt, giving a net cash position of -3.85B.

Cash & Cash Equivalents	468M
Total Debt	4.32B
Net Cash	-3.85B
Retained Earnings	-1.95B
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 541M and capital expenditures -147M, giving a free cash flow of 394M.

Operating Cash Flow	541M
Capital Expenditures	-147M
Free Cash Flow	394M
FCF Per Share	0.8

Full Cash Flow Statement

Margins

Gross margin is 43.01%, with operating and profit margins of 5.65% and 7.61%.

Gross Margin	43.01%
Operating Margin	5.65%
Pretax Margin	10.99%
Profit Margin	7.61%
EBITDA Margin	5.65%
EBIT Margin	5.65%
FCF Margin	8.88%

Dividends & Yields

ELAT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	3.21%
FCF Yield	3.74%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ELAT.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	13.78
Graham Upside	-35.37%

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a